MedTrace Logo

Dexmedetomidine Versus Magnesium Sulfate Infusion During Spinal Anesthesia

NCT03640390 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-11-14

No results posted yet for this study

Summary

The aim of this work is to compare the hemodynamic and analgesic properties of Dexmedetomidine and Magnesium sulphate infusion in lower abdominal surgery.

Conditions

  • Postoperative Pain

Interventions

DRUG

Dexmedetomidine

This group will receive Dexmedetomidine infusion at a rate of 0.5 mcg/kg/hour.

DRUG

Magnesium Sulphate

This group will receive Magnesium sulphate infusion at a rate of 15 mg/Kg/hour

DRUG

Normal saline

This group will receive normal saline infusion

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Inas Farouk, Lecturer · Lecturer of anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-30
Primary Completion
2019-08-30
Completion
2019-09-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03640390 on ClinicalTrials.gov